Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronomic Tegafur/Uracil in Locally Advanced HNSCC
NCT00855881Phase 2Unknown
- Sponsor
- Mackay Memorial Hospital
- Start
- Dec 2008
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tegafur + uracil in head and neck squamous cell carcinoma (HNSCC), sponsored by Mackay Memorial Hospital. Primary endpoint: Recurrence-Free Survival at 2 years. Status: unknown.
02
Drugs
tegafur + uracil
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00855881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00855881.